Skip to Content

N I 400 (Imatinib Mesylate 400 mg)

Pill with imprint N I 400 is Brown, Elliptical / Oval and has been identified as Imatinib Mesylate 400 mg. It is supplied by Lupin Pharmaceuticals, Inc..

Imatinib is used in the treatment of chronic myelogenous leukemia; acute lymphoblastic leukemia; chronic eosinophilic leukemia; dermatofibrosarcoma protuberans; gastrointestinal stromal tumor and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Imatinib 400 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for N I 400

Imatinib Mesylate

N I 400
400 mg
Elliptical / Oval
Prescription only
Drug Class
Bcr-abl tyrosine kinase inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Lupin Pharmaceuticals, Inc.
Natco Pharma Limited
National Drug Code (NDC)

Get help with Imprint Code FAQs.

Related Images for "N I 400"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.